Update
$Savara (SVRA.US)$ Reuters· justSavara Initiates Rolling Submission of a Biologics License Application (Bla) to the U.S. Food and Drug Administration (FDA) for Molbreevi* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Apap)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
2